Publication | Closed Access

Synthesis, biological assessment and molecular modeling of new multipotent MAO and cholinesterase inhibitors as potential drugs for the treatment of Alzheimer’s disease

Molecular PharmacologyNeurodegenerative DiseasesAlzheimer's DiseaseNew Multipotent MaoMedicineRational Drug DesignPharmacological AgentNeuropharmacologyBiological AssessmentNeurologyNeuroscienceCholinesterase InhibitorsPharmacologyDrug Discovery